I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| classical monocyte | 17 studies | 31% ± 12% | |
| conventional dendritic cell | 16 studies | 33% ± 14% | |
| ciliated cell | 13 studies | 30% ± 10% | |
| non-classical monocyte | 12 studies | 30% ± 12% | |
| monocyte | 12 studies | 25% ± 8% | |
| platelet | 9 studies | 34% ± 12% | |
| macrophage | 9 studies | 21% ± 4% | |
| dendritic cell | 8 studies | 38% ± 15% | |
| gamma-delta T cell | 8 studies | 19% ± 3% | |
| CD8-positive, alpha-beta T cell | 7 studies | 19% ± 3% | |
| natural killer cell | 7 studies | 20% ± 5% | |
| CD16-positive, CD56-dim natural killer cell, human | 6 studies | 19% ± 2% | |
| regulatory T cell | 6 studies | 19% ± 3% | |
| effector memory CD8-positive, alpha-beta T cell | 5 studies | 19% ± 2% | |
| exhausted T cell | 4 studies | 22% ± 6% | |
| megakaryocyte | 4 studies | 32% ± 13% | |
| effector CD8-positive, alpha-beta T cell | 4 studies | 19% ± 2% | |
| hematopoietic stem cell | 4 studies | 28% ± 15% | |
| mononuclear phagocyte | 3 studies | 29% ± 11% | |
| pericyte | 3 studies | 22% ± 2% | |
| myeloid cell | 3 studies | 27% ± 5% | |
| effector CD4-positive, alpha-beta T cell | 3 studies | 21% ± 1% | |
| double negative thymocyte | 3 studies | 20% ± 1% | |
| microglial cell | 3 studies | 21% ± 4% |
